Review article · 2020 · Open access
Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases
International Journal of Nanomedicine, Volume 15, 3741–3769 · Published 1 May 2020 · DOI 10.2147/ijn.s250872
In brief
“Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases” is a 2020 review article by Rajasekharreddy Pala and 4 co-authors, published in International Journal of Nanomedicine. OpenAlex counts 230 citations as of 19 November 2026, which puts it in the top 7% of works published in 2020 by citations. It is open access under a CC BY-NC licence: the full text is free to read at International Journal of Nanomedicine.
- Citations
- 230
- Most cited in
- 2025 (50)
- Field-weighted impact
- 1.61
- References
- 192
- Authors
- 5
Abstract
Cardiovascular diseases (CVDs) are one of the foremost causes of high morbidity and mortality globally. Preventive, diagnostic, and treatment measures available for CVDs are not very useful, which demands promising alternative methods. Nanoscience and nanotechnology open a new window in the area of CVDs with an opportunity to achieve effective treatment, better prognosis, and less adverse effects on non-target tissues. The application of nanoparticles and nanocarriers in the area of cardiology has gathered much attention due to the properties such as passive and active targeting to the cardiac tissues, improved target specificity, and sensitivity. It has reported that more than 50% of CVDs can be treated effectively through the use of nanotechnology. The main goal of this review is to explore the recent advancements in nanoparticle-based cardiovascular drug carriers. This review also summarizes the difficulties associated with the conventional treatment modalities in comparison to the nanomedicine for CVDs.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Pala, R., Anju, V. T., Dyavaiah, M., Busi, S., & Nauli, S. M. (2020). Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases. International Journal of Nanomedicine, Volume 15, 3741–3769. https://doi.org/10.2147/ijn.s250872
MLA 9
Pala, Rajasekharreddy, et al. “Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases.” International Journal of Nanomedicine, vol. Volume 15, 2020, pp. 3741–3769. https://doi.org/10.2147/ijn.s250872.
Chicago
Pala, Rajasekharreddy, V. T. Anju, Madhu Dyavaiah, Siddhardha Busi, and Surya M. Nauli. 2020. “Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases.” International Journal of Nanomedicine Volume 15: 3741–3769. https://doi.org/10.2147/ijn.s250872.
Harvard
Pala, R. et al. (2020) ‘Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases’, International Journal of Nanomedicine, Volume 15, pp. 3741–3769. doi:10.2147/ijn.s250872.
IEEE
R. Pala, V. T. Anju, M. Dyavaiah, S. Busi, and S. M. Nauli, “Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases,” International Journal of Nanomedicine, vol. Volume 15, pp. 3741–3769, 2020, doi: 10.2147/ijn.s250872.
BibTeX
@article{pala2020nanoparticle,
title = {{Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases}},
author = {Pala, Rajasekharreddy and Anju, V. T. and Dyavaiah, Madhu and Busi, Siddhardha and Nauli, Surya M.},
journal = {International Journal of Nanomedicine},
year = {2020},
volume = {Volume 15},
pages = {3741--3769},
doi = {10.2147/ijn.s250872},
url = {https://doi.org/10.2147/ijn.s250872}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2020 | 2 | |
| 2021 | 16 | |
| 2022 | 36 | |
| 2023 | 48 | |
| 2024 | 48 | |
| 2025 | 50 | |
| 2026 | 30 |
Its field-weighted citation impact is 1.61: it has been cited 1.61 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- nanoparticle drug delivery
- cardiovascular disease
- nanocarriers
- targeted drug delivery
- passive targeting
- active targeting
- nanomedicine
Work with this paper
Most-cited papers in Materials Science
- Electric Field Effect in Atomically Thin Carbon FilmsKostya S. Novoselov, Andre K. Geim, Sergey V. Morozov and 5 more · Science · 2004 · 67,474 citations
- Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenidesROBERT D. SHANNON · Acta Crystallographica Section A · 1976 · 66,944 citations
- Ab initio molecular dynamics for liquid metalsGeorg Kresse, J. Häfner · Physical review. B, Condensed matter · 1993 · 46,320 citations
- Helical microtubules of graphitic carbonSumio Iijima · Nature · 1991 · 43,639 citations
- The rise of grapheneAndre K. Geim, Kostya S. Novoselov · Nature Materials · 2007 · 40,328 citations
Questions about this paper
How do I cite this paper in APA style?
Pala, R., Anju, V. T., Dyavaiah, M., Busi, S., & Nauli, S. M. (2020). Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases. International Journal of Nanomedicine, Volume 15, 3741–3769. https://doi.org/10.2147/ijn.s250872
How many times has this paper been cited?
230 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at International Journal of Nanomedicine: sign in and open the PDF from this page.
Who wrote this paper?
Rajasekharreddy Pala, V. T. Anju, Madhu Dyavaiah, Siddhardha Busi, Surya M. Nauli.
What is the DOI of this paper?
10.2147/ijn.s250872, permanently at https://doi.org/10.2147/ijn.s250872. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.